Literature DB >> 24102098

MicroRNAs in the onset and development of cardiovascular disease.

Kasey C Vickers1, Kerry-Anne Rye, Fatiha Tabet.   

Abstract

Physiological and pathological roles for small non-encoding miRNAs (microRNAs) in the cardiovascular system have recently emerged and are now widely studied. The discovery of widespread functions of miRNAs has increased the complexity of gene-regulatory processes and networks in both the cardiovascular system and cardiovascular diseases. Indeed, it has recently been shown that miRNAs are implicated in the regulation of many of the steps leading to the development of cardiovascular disease. These findings represent novel aspects in miRNA biology and, therefore, our understanding of the role of these miRNAs during the pathogenesis of cardiovascular disease is critical for the development of novel therapies and diagnostic interventions. The present review will focus on understanding how miRNAs are involved in the onset and development of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24102098      PMCID: PMC3873876          DOI: 10.1042/CS20130203

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  150 in total

1.  miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells.

Authors:  Amit K Pandey; Gaurav Verma; Saurabh Vig; Swayamprakash Srivastava; Arvind K Srivastava; Malabika Datta
Journal:  Mol Cell Endocrinol       Date:  2010-10-11       Impact factor: 4.102

2.  MicroRNA-155 regulates lipid uptake, adhesion/chemokine marker secretion and SCG2 expression in oxLDL-stimulated dendritic cells/macrophages.

Authors:  Ting Chen; Hui Yan; Zhoubin Li; Tu Jing; Weiguo Zhu; Junhua Ge; Xiaoye Zheng; Xiaoping Pan; Hui Yan; Jianhua Zhu
Journal:  Int J Cardiol       Date:  2011-01-26       Impact factor: 4.164

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1).

Authors:  Timothy J Pullen; Gabriela da Silva Xavier; Gavin Kelsey; Guy A Rutter
Journal:  Mol Cell Biol       Date:  2011-06-06       Impact factor: 4.272

5.  miR-122 regulates hepatic lipid metabolism and tumor suppression.

Authors:  Jessica Wen; Joshua R Friedman
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

6.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

7.  First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome.

Authors:  Johannes Kapeller; Lesley A Houghton; Hubert Mönnikes; Jutta Walstab; Dorothee Möller; Heinz Bönisch; Barbara Burwinkel; Frank Autschbach; Benjamin Funke; Felix Lasitschka; Nikolaus Gassler; Christine Fischer; Peter J Whorwell; Wendy Atkinson; Catherine Fell; Karl J Büchner; Marco Schmidtmann; Ivo van der Voort; Anna-Sophia Wisser; Thomas Berg; Gudrun Rappold; Beate Niesler
Journal:  Hum Mol Genet       Date:  2008-07-09       Impact factor: 6.150

8.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

9.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

10.  Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol.

Authors:  Xiao Sun; Man Zhang; Akimasa Sanagawa; Chieko Mori; Shiori Ito; Soichiro Iwaki; Hiroki Satoh; Satoshi Fujii
Journal:  Thromb J       Date:  2012-08-28
View more
  46 in total

Review 1.  Calcineurin signaling in the heart: The importance of time and place.

Authors:  Valentina Parra; Beverly A Rothermel
Journal:  J Mol Cell Cardiol       Date:  2016-12-20       Impact factor: 5.000

2.  Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods.

Authors:  Hjalte H Andersen; Meg Duroux; Parisa Gazerani
Journal:  Mol Neurobiol       Date:  2015-02-01       Impact factor: 5.590

3.  MicroRNA-21 Contributes to Reduced Microvascular Function in Binge Drinking Young Adults.

Authors:  Jing-Tan Bian; Mariann R Piano; Kumar U Kotlo; Abeer M Mahmoud; Shane A Phillips
Journal:  Alcohol Clin Exp Res       Date:  2017-12-27       Impact factor: 3.455

4.  Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients.

Authors:  F I Parthenakis; M E Marketou; J E Kontaraki; F Maragoudakis; S Maragkoudakis; H Nakou; K Roufas; A Patrianakos; G Chlouverakis; N Malliaraki; P E Vardas
Journal:  J Hum Hypertens       Date:  2016-03-17       Impact factor: 3.012

5.  Platelet-derived miR-92a downregulates cysteine protease inhibitor cystatin C in type II diabetic lower limb ischemia.

Authors:  Yunfeng Zhang; Qiang Guan; Xing Jin
Journal:  Exp Ther Med       Date:  2015-04-01       Impact factor: 2.447

Review 6.  Epigenetic mechanisms in heart development and disease.

Authors:  Shannalee R Martinez; Maresha S Gay; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-01-06       Impact factor: 7.851

7.  Multiplexed microRNA Expression Profiling by Combined Asymmetric PCR and Label-Free Detection using Silicon Photonic Sensor Arrays.

Authors:  Richard M Graybill; Maria C Cardenosa-Rubio; Hongwei Yang; Mark D Johnson; Ryan C Bailey
Journal:  Anal Methods       Date:  2018-03-23       Impact factor: 2.896

Review 8.  Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.

Authors:  Manuel A Valenzuela; Jimena Canales; Alejandro H Corvalán; Andrew F G Quest
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 9.  2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development.

Authors:  Yanfang Peipei Zhu; Graham D Thomas; Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-07       Impact factor: 8.311

Review 10.  Role of miRNAs in hypoxia-related disorders.

Authors:  A Gupta; R Sugadev; Y K Sharma; Y Yahmad; P Khurana
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.